Azziz R., Dumesic D., Chazenbalk G., Goodarzi M. 2013. Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis. Nat. Rev. Endocrinol. 7 (4), 219‒231.
Knochenhauer E., Key T., Kahsarmiller M., Waggoner W., Boots L., Azziz R. 1998. The endocrine society prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: A prospective study. J. Clin. Endocr. Metab. 83, 3078‒3082.
Azziz R., Carmina E., Chen Z., Dunaif A., Laven J. 2016. Polycystic ovary syndrome. Nat. Rev. Dis. Primers. 2, 16057.
Dabravolski S.A., Nikiforov N.G., Eid A.H., Nedosugova L.V., Starodubova A.V., Popkova T.V., Bezsonov E.E., Orekhov A.N. 2021. Mitochondrial dysfunction and chronic inflammation in polycystic ovary syndrome. Int. J. Mol. Sci. 8, 3923.
Jerkovic L., Voegele A.F., Chwatal S., Kronenberg F., Radcliffe C.M., Wormald M.R., Lobentanz E.M., Ezeh B., Eller P., Dejori N., Dieplinger B., Lottspeich F., Sattler W., Uhr M., Mechtler K., Dwek R.A., Rudd P.M., Baier G., Dieplinger H. 2005. Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expression. J. Proteome Res. 4 (3), 889‒899.
Article CAS PubMed Google Scholar
Seeber B.E., Czech T., Buchner H., Kurzthaler D., Wildt L., Dieplinger H. 2008. Afamin, a vitamin e-binding protein elevated in metabolic syndrome, is significantly increased in women with polycystic ovarian syndrome, regardless of insulin resistance. Fertil. Steril. 90 (Suppl.), S14‒S15.
Voegele A., Lidija Jerković,Wellenzohn B., Eller P., Kronenberg F., Liedl K. 2002. Characterization of the vitamin E-binding properties of human plasma afamin. Biochemistry. 41, 14532‒14538.
Article CAS PubMed Google Scholar
Jerkovic L., Dieplinger H., Eller P., Voegele A., Urh M., Moncayo H., Soelder E., Wolf H., Illmensee K. 1999. P-124. Afamin and vitamin E in follicular fluid of patients undergoing IVF. Hum. Reproduct. 14 (Suppl. 3), 203.
Dieplinger B., Egger M., Gabriel C., Poelz W., Morandell E., Seeber B., Kronenberg F., Haltmayer M., Mueller T., Dieplinger H. 2013. Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma. Clin. Chim. Acta. 425, 236‒241.
Article CAS PubMed PubMed Central Google Scholar
Dieplinger H., Dieplinger B. 2015. Afamin—a pleiotropic glycoprotein involved in various disease states. Clin. Chim. Acta. 446, 105‒110.
Article CAS PubMed Google Scholar
Vatassery G.T., Nelson M.J., Maletta G.J., Kuskowski M.A. 1991. Vitamin E (tocopherols) in human cerebrospinal fluid. Am. J. Clin. Nutrition. 53 (1), 95‒99.
Lichenstein H., Lyons D., Wurfel M., Johnson D., McGinley M., Leidli J., Trollinger D., Mayer J., Wright S., Zukowski M. 1994. Afamin is a new member of the albumin, alpha-fetoprotein, and vitamin D-binding protein gene family J. Biol. Chem. 269 (27), 18149–18154.
Article CAS PubMed Google Scholar
Li L., Zhang J., Zeng J., Liao B., Peng X., Li T., Li J., Tan Q., Li X., Yang Y., Chen Z., Liang Z. 2020. Proteomics analysis of potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome. Int. J. Mol. Med. 45 (5), 1409‒1416.
CAS PubMed PubMed Central Google Scholar
Lai F., Liu J., Li L., Ma J., Shen W. 2016. Di(2-ethylhexyl) phthalate impairs steroidogenesis in ovarian follicular cells of prepuberal mice. Arch. Toxicol. 91 (3), 1279‒1292.
Lai N., Xiang N., Li N., Li Y. 2018. Oxidative stress in granulosa cells contributes to poor oocyte quality and IVF-ET outcomes in women with polycystic ovary syndrome. Front. Med. 12 (5), 518‒524.
Endocrinology Subgroup and Expert Panel, Chinese Society of Obstetrics and Gyneocology and Chinese Medical Association. 2018. Chinese guideline for diagnosis and management of polycystic ovary syndrome. Zhonghua Fu Chan Ke Za Zhi. 53, 2–6. https://doi.org/10.3760/cma.j.issn.0529-567X.2018.01.002
Franks S. 2018. Commentary: the new international guideline for diagnosis and management of PCOS was worth the effort. Clin. Endocrinol. 90, 265‒266.
Rosenfield R., Ehrmann D. 2016. The pathogenesis of polycystic ovary syndrome (PCOS). Endocr. Rev. 37, 2015‒1104.
Luo M., Huang J.C., Yang Z.Q., Wang Y.S., Guo B., Yue Z.P. 2020. Hydroxysafflor yellow A exerts beneficial effects by restoring hormone secretion and alleviating oxidative stress in polycystic ovary syndrome mice. Exp. Physiol. 105 (2), 282‒292.
Article CAS PubMed Google Scholar
Wan J., Liu S. 2020. Rosiglitazone ameliorates palmitic acid-induced endoplasmic reticulum stress and steroidogenic capacity in granulosa cells. Reprod. Biol. 20 (3), 293‒229.
Rudnicka E., Duszewska A.M., Kucharski M., Tyczyński P., Smolarczyk R. 2022. Oxidative stress and reproductive function: Oxidative stress in polycystic ovary syndrome. Reproduction. 164 (6), F145‒F154.
Article CAS PubMed Google Scholar
Yu R., Lin J., Zhao J., Wang P., Xiao S. 2012. Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer. Zhonghua Fu Chan Ke Za Zhi. 47, 250.
Qiao J., Feng H. 2011. Extra- and intra-ovarian factors in polycystic ovary syndrome: Impact on oocyte maturation and embryo developmental competence. Hum. Reprod. Update. 17, 17‒33.
Han A., Kim H., Cha S., Park C., Kim J. 2011. Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: A case-control study. Clin. Exp. Reprod. Med. 38, 103‒108.
Article PubMed PubMed Central Google Scholar
Comim F., Hardy K., Franks S. 2013. Adiponectin and its receptors in the ovary: Further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome. PLoS One. 8, e80416.
Article PubMed PubMed Central Google Scholar
Qi X., Zhang B., Zhao Y., Li R., Chang H.M., Pang Y., Qiao J. 2017. Hyperhomocysteinemia promotes insulin resistance and adipose tissue inflammation in PCOS mice through modulating M2 macrophage polarization via estrogen suppression. Endocrinology. 158 (5), 1181‒1193.
Article CAS PubMed Google Scholar
Nikbakht R., Mohammadjafari R., Rajabalipour M., Moghadam M.T. 2021. Evaluation of oocyte quality in polycystic ovary syndrome patients undergoing ART cycles. Fertil. Res. Pract. 7 (1), 2.
Article PubMed PubMed Central Google Scholar
Kollerits B., Lamina C., Huth C., Marques-Vidal P., Kiechl S., Seppälä I., Cooper J., Hunt S.C., Meisinger C., Herder C., Kedenko L., Willeit J., Thorand B., Dähnhardt D., Stöckl D., Willeit K., Roden M., Rathmann W., Paulweber B., Peters A., Kähönen M., Lehtimäki T., Raitakari O.T., Humphries S.E., Vollenweider P., Dieplinger H., Kronenberg F. 2017. Plasma concentrations of afamin are associated with prevalent and incident type 2 diabetes: A pooled analysis in more than 20,000 individuals. Diabetes Care. 40 (10), 1386‒1393.
Article CAS PubMed Google Scholar
Nuez-Calonge R., Cortes S., Caballero Peregrín P., Gutierrez Gonzalez L.M., Kireev R. 2021. Seminal plasma and serum afamin levels are associated with infertility in men with oligoasthenoteratozoospermia. Reprod. Sci. 28 (5), 1498‒1506.
Kheiripour N., Khodamoradi Z., Ranjbar A., Borzouei S. 2021. The positive effect of short-term nano-curcumin therapy on insulin resistance and serum levels of afamin in patients with metabolic syndrome. Avicenna J. Phytomed. 11, 146‒153.
CAS PubMed PubMed Central Google Scholar
Seeber B., Morandell E., Lunger F., Wildt L., Dieplinger H. 2014. Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome. Reprod. Biol. Endocrinol. 12, 88.
Article PubMed PubMed Central Google Scholar
Yuan Y., He W., Fan X., Liang J., Cao Z., Li L. 2023. Serum afamin levels in predicting gestational diabetes mellitus and preeclampsia: A systematic review and meta-analysis. Front. Endocrinol. (Lausanne). 14, 1157114.
Köninger A., Iannaccone A., Hajder E., Frank M., Schmidt B., Schleussner E., Kimmig R., Gellhaus A., Dieplinger H. 2019. Afamin predicts gestational diabetes in polycystic ovary syndrome patients preconceptionally. Endocr. Connect. 8 (5), 616‒624.
留言 (0)